145 related articles for article (PubMed ID: 20411171)
1. The legal standards for the radioactive or non radioactive drugs research and approval in the European Community and in Germany after the thalidomide catastrophe.
Barsch M; Otte A
Hell J Nucl Med; 2010; 13(1):45-51. PubMed ID: 20411171
[TBL] [Abstract][Full Text] [Related]
2. [The Neurosedyn disaster became a starting shot. The drug approval process was changed and new era of patient safety was initiated].
Asberg KH
Lakartidningen; 2011 Nov 30-Dec 6; 108(48):2486-7. PubMed ID: 22462269
[No Abstract] [Full Text] [Related]
3. [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation].
Maio G
Dtsch Med Wochenschr; 2001 Oct; 126(42):1183-6. PubMed ID: 11607860
[No Abstract] [Full Text] [Related]
4. Changing requirements for evaluation of pharmacologic agents.
Chesney RW; Christensen ML
Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
[TBL] [Abstract][Full Text] [Related]
5. [Controversial expertise. The "Scientific Advisory Committee for Drug Safety" and its role in drug regulation in the Federal Republic of Germany, 1968-1976].
Kessel N
Medizinhist J; 2009; 44(1):61-93. PubMed ID: 19499602
[TBL] [Abstract][Full Text] [Related]
6. [Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A].
Henschler D
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):600-3. PubMed ID: 9527449
[TBL] [Abstract][Full Text] [Related]
7. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
Shulman SR; Brown JS
Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
[No Abstract] [Full Text] [Related]
8. [Sharpness, Parliamentary Ombudsman!].
Axelsson I
Lakartidningen; 2003 Aug; 100(32-33):2534. PubMed ID: 12959016
[No Abstract] [Full Text] [Related]
9. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action and potential therapeutic uses of thalidomide.
Mujagić H; Chabner BA; Mujagić Z
Croat Med J; 2002 Jun; 43(3):274-85. PubMed ID: 12035132
[TBL] [Abstract][Full Text] [Related]
11. [Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry].
Zierenberg O
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):596-600. PubMed ID: 9527448
[TBL] [Abstract][Full Text] [Related]
12. Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe.
Boon WP; Moors EH; Meijer A; Schellekens H
Clin Pharmacol Ther; 2010 Dec; 88(6):848-53. PubMed ID: 20962774
[TBL] [Abstract][Full Text] [Related]
13. Future European health care: cost containment, health care reform and scientific progress in drug research.
Emilien G
Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
[TBL] [Abstract][Full Text] [Related]
14. Cancer drug approval in the United States, Europe, and Japan.
Milsted RA
Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic studies in pregnant women.
Anger GJ; Piquette-Miller M
Clin Pharmacol Ther; 2008 Jan; 83(1):184-7. PubMed ID: 17882157
[TBL] [Abstract][Full Text] [Related]
16. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
17. Towards a harmonized radiopharmaceutical regulatory framework in Europe?
Decristoforo A; Peñuelas I
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):394-401. PubMed ID: 19834449
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide: 40 years on.
Diggle GE
Int J Clin Pract; 2001 Nov; 55(9):627-31. PubMed ID: 11770361
[TBL] [Abstract][Full Text] [Related]
19. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
Grienenberger A
J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
[TBL] [Abstract][Full Text] [Related]
20. Show drugs work before selling them.
Sipp D; McCabe C; Rasko JE
Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
